SEP 08, 2016 1:30 PM PDT

The Paradigm Shift in Clinical Microbiology

Speaker
  • Scientific Affairs Manage, Roche
    Biography
      Steven is currently a Scientific Affairs Manager within the Medical and Scientific Affairs organization. He is responsible for interfacing with clinicians and key opinion leaders to assist in commercialization of products within the Roche Molecular Diagnostics portfolio. Steven has expertise in Donor Screening using both the cobas s201 platform as well as the cobas 6800 and 8800. He is also the lead for the Microbiology assays for Molecular MSA.

      Steven has worked at Roche for 5 years in several capacities. He worked directly with customers as part of Global Customer Support by handling complaints as well as assisting customers on site. He has also worked as part of the Operations Investigation Unit to perform quality investigations related to all kits and components manufactured at RMS. Steven has a bachelor's degree in Biotechnology from Rutgers University and a Ph.D. in Microbiology and Molecular Genetics from the University of Medicine and Dentistry of New Jersey.

      Steven currently lives with his wife, Marta, in Raritan, New Jersey.

    Abstract

    Multi-Drug Resistant Organisms (MDROs) are becoming a bigger and bigger concern throughout the world. Antibiotic resistance forms and spreads faster than pharmaceutical companies have been able to develop new antibiotic compounds. This stagnation in the development of new tools for the clinical laboratory to identify these organisms has equally been a problem. The traditional methods we use to identify and determine antibiotic resistance and susceptibility have not significantly changed for at least 50 years. Although these techniques are effective, they continue to require highly skilled staff, and multiple days to get a definitive result. Novel technologies, like Smarticles, are in development today with the goal to help identify drug resistant organisms the same day that samples are collected with automated systems. Technologies like Smarticles provide the promise of significantly improving our ability to identify carriers of these organisms and prevent them from spreading to other patients in the hospital.
    Dr. Cagas will give an overview of the growing threat that MDROs pose, how Clinical Microbiology has evolved to where it is today, and how novel technologies, like Smarticles, have the potential to cause a significant paradigm shift for clinical laboratories and the hospitals they serve.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    SEP 08, 2016 1:30 PM PDT

    The Paradigm Shift in Clinical Microbiology


    Specialty

    Microbiology

    Immunology

    Molecular Biology

    Molecular Diagnostics

    Research

    Neuroscience

    Cancer Research

    Research And Development

    Biotechnology

    University

    Clinical Oncology

    Hiv

    Parasitology

    Cancer Diagnostics

    Chemistry

    Geography

    North America57%

    Asia29%

    South America14%

    Registration Source

    Website Visitors100%

    Job Title

    Medical Laboratory Technician29%

    Clinical Laboratory Scientist14%

    Facility/Department Manager14%

    Medical Doctor/Specialist14%

    Microbiologist14%

    Chemist14%

    Organization

    Academic Institution29%

    Independent Laboratories14%

    Manufacturer - Other14%

    Hospital14%

    Clinical Laboratory14%

    Other14%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more